July 30, 2021 - ROSEN LOGO.jpg
全球投資者法律顧問 ROSEN 鼓勵 Outset Medical, Inc. 投資者在對 OM 提起證券集體訴訟的重要截止日期前聘請律師
September 22, 2024 08:00 ET | The Rosen Law Firm PA
紐約, Sept. 22, 2024 (GLOBE NEWSWIRE) -- 事因:全球投資者權益律師事務所 Rosen Law Firm 提醒在 2022 年 8 月 1 日至 2024 年 8 月 7 日(包括首尾兩日,簡稱「集體訴訟期」)期間購買了 Outset Medical, Inc. 證券(NASDAQ: OM)之人士注意,重要的首席原告截止日期為 2024 年 10 月 28...
July 30, 2021 - ROSEN LOGO.jpg
רוזן, יועץ למשקיעים גלובלי, מעודד את משקיעי Outset Medical, Inc. לקבל ייעוץ לפני תאריך יעד חשוב בתביעה ייצוגית בניירות ערך – OM
September 22, 2024 08:00 ET | The Rosen Law Firm PA
ניו יורק, Sept. 22, 2024 (GLOBE NEWSWIRE) -- מדוע: משרד רוזן עורכי דין (Rosen Law Firm), משרד עורכי דין בינלאומי העוסק בזכויות משקיעים, מזכיר לרוכשים את ניירות הערך של Outset Medical, Inc.(נאסד"ק:...
July 30, 2021 - ROSEN LOGO.jpg
ROSEN, GLOBAL INVESTOR COUNSEL, Encourages Outset Medical, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – OM
September 22, 2024 08:00 ET | The Rosen Law Firm PA
NEW YORK, Sept. 22, 2024 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Outset Medical, Inc. (NASDAQ: OM) between August 1, 2022...
July 30, 2021 - ROSEN LOGO.jpg
ROSEN, NATIONALLY REGARDED INVESTOR COUNSEL, Encourages Orthofix Medical Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – OFIX
September 22, 2024 07:20 ET | The Rosen Law Firm PA
NEW YORK, Sept. 22, 2024 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of Orthofix Medical Inc. (NASDAQ: OFIX) between October 11,...
July 30, 2021 - ROSEN LOGO.jpg
全國知名投資者法律顧問 ROSEN 鼓勵 Orthofix Medical Inc. 投資者在證券集體訴訟的重要截止日期前聘請律師 – OFIX
September 22, 2024 07:20 ET | The Rosen Law Firm PA
紐約, Sept. 22, 2024 (GLOBE NEWSWIRE) -- 事因:全球投資者權益律師事務所 Rosen Law Firm 提醒在 2022 年 10 月 11 日至 2023 年 9 月 12 日(包括首尾兩日,下稱「集體訴訟期」)期間購買了 Orthofix Medical Inc. 普通股(NASDAQ:OFIX)之人士注意,重要的首席原告截止日期為 2024 年...
Logo.png
Graft versus Host Disease Market to Increase at a CAGR of 9.9% During the Study Period (2020–2034) | DelveInsight
September 22, 2024 00:30 ET | DelveInsight Business Research LLP
New York, USA, Sept. 22, 2024 (GLOBE NEWSWIRE) -- Graft versus Host Disease Market to Increase at a CAGR of 9.9% During the Study Period (2020–2034) | DelveInsight  The graft versus host disease...
BES_Mark.jpg
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against MacroGenics and Vicor and Encourages Investors to Contact the Firm
September 21, 2024 21:00 ET | Bragar Eagel & Squire
NEW YORK, Sept. 21, 2024 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, reminds investors that class actions have been commenced on behalf...
BES_Mark.jpg
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Moderna, Lululemon, XPEL, and Nano Nuclear and Encourages Investors to Contact the Firm
September 21, 2024 21:00 ET | Bragar Eagel & Squire
NEW YORK, Sept. 21, 2024 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, reminds investors that class actions have been commenced on behalf...
BES_Mark.jpg
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against WEBTOON, Verve, and Ardelyx and Encourages Investors to Contact the Firm
September 21, 2024 21:00 ET | Bragar Eagel & Squire
NEW YORK, Sept. 21, 2024 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, reminds investors that class actions have been commenced on behalf...
BES_Mark.jpg
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Indivior, CrowdStrike, DXC, and Five Below and Encourages Investors to Contact the Firm
September 21, 2024 21:00 ET | Bragar Eagel & Squire
NEW YORK, Sept. 21, 2024 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, reminds investors that class actions have been commenced on behalf...